Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The effect of adipose-derived mesenchymal stem cell transplantation on ovarian mitochondrial dysfunction in letrozole-induced polycystic ovary syndrome in rats: the role of PI3K-AKT signaling pathway.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101474849 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-2215 (Electronic) Linking ISSN: 17572215 NLM ISO Abbreviation: J Ovarian Res Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, c2008-
    • الموضوع:
    • نبذة مختصرة :
      Objective: The present study aimed to elucidate how mesenchymal stem cells (MSCs) application could efficiently attenuate pathological changes of letrozole-induced poly cystic ovary syndrome (PCOS) by modulating mitochondrial dynamic via PI3K-AKT pathway.
      Methods: Thirty-two female rats were randomly divided into four experimental groups: Sham, PCOS, PCOS + MSCs, and PCOS + MSCs + LY294002. The Sham group received 0.5% w/v carboxymethyl cellulose (CMC); the PCOS group received letrozole (1 mg/kg, daily) in 0.5% CMC for 21 days. Animals in the PCOS + MSCs group received 1 × 10 6 MSCs/rat (i.p,) on the 22th day of the study. In the PCOS + MSCs + LY294002 group, rats received LY294002 (PI3K-AKT inhibitor) 40 min before MSC transplantation. Mitochondrial dynamic gene expression, mitochondrial membrane potential (MMP), citrate synthase (CS) activity, oxidative stress, inflammation, ovarian histological parameters, serum hormone levels, homeostatic model assessment for insulin resistance (HOMA-IR), insulin and glucose concentrations, p-PI3K and p-AKT protein levels were evaluated at the end of the experiment.
      Results: PCOS rats showed a significant disruption of mitochondrial dynamics and histological changes, lower MMP, CS, ovary super oxide dismutase (SOD) and estrogen level. They also had a notable rise in insulin and glucose concentrations, HOMA-IR, testosterone level, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels, ovarian malondialdehyde (MDA) content as well as a notable decrease in p-PI3K and p-AKT protein levels compared to the Sham group. In the PCOS + MSCs group, the transplantation of MSCs could improve the above parameters. Administration of LY294002 (PI3K-AKT pathway inhibitor) deteriorated mitochondrial dynamic markers, oxidative stress status, inflammation markers, hormonal levels, glucose, and insulin levels and follicular development compared to the PCOS + MSCs group.
      Conclusions: This study demonstrated that the protective effects of MSC transplantation in regulating mitochondrial dynamics, promoting mitochondrial biogenesis, competing with redox status and inflammation response were mainly mediated through the PI3K-AKT pathway in the PCOS model.
      (© 2024. The Author(s).)
    • References:
      Int J Fertil Steril. 2017 Apr-Jun;11(1):47-55. (PMID: 28367305)
      Hum Reprod. 2004 Jan;19(1):41-7. (PMID: 14688154)
      Cell Death Differ. 2017 Jul;24(7):1224-1238. (PMID: 28524859)
      Adv Pharm Bull. 2020 Jun;10(2):297-306. (PMID: 32373500)
      Mol Neurobiol. 2020 Sep;57(9):3633-3645. (PMID: 32562236)
      J Cell Biochem. 2012 May;113(5):1527-36. (PMID: 22173988)
      Stem Cells. 2008 Jan;26(1):135-45. (PMID: 17932426)
      Stem Cell Res Ther. 2022 Feb 2;13(1):49. (PMID: 35109928)
      Life Sci. 2019 Nov 15;237:116911. (PMID: 31606385)
      Arch Biochem Biophys. 2019 Aug 15;671:245-254. (PMID: 31251923)
      Inflammopharmacology. 2020 Apr;28(2):585-601. (PMID: 31741175)
      Reprod Biol Endocrinol. 2023 Aug 1;21(1):70. (PMID: 37528417)
      Int J Fertil Steril. 2023 Nov 07;18(1):45-53. (PMID: 38041459)
      Stem Cells. 2017 Dec;35(12):2331-2339. (PMID: 28856759)
      Gynecol Endocrinol. 2022 Jan;38(1):2-9. (PMID: 34787028)
      Int J Mol Med. 2019 Jan;43(1):316-324. (PMID: 30431108)
      Horm Mol Biol Clin Investig. 2023 Mar 02;44(3):277-284. (PMID: 36855920)
      Mitochondrion. 2020 May;52:24-39. (PMID: 32081727)
      J Allergy Clin Immunol. 2019 May;143(5):1943-1945.e4. (PMID: 30677479)
      Reprod Biol Endocrinol. 2019 Aug 16;17(1):67. (PMID: 31420039)
      Diseases. 2016 Dec 23;5(1):. (PMID: 28933354)
      Cells. 2020 Oct 08;9(10):. (PMID: 33050021)
      Nat Commun. 2019 Apr 1;10(1):1473. (PMID: 30931927)
      Cell Physiol Biochem. 2014;34(6):2245-55. (PMID: 25562170)
      Int Immunopharmacol. 2018 Jan;54:86-94. (PMID: 29112894)
      Cell Transplant. 2016;25(5):829-48. (PMID: 26423725)
      Aging Cell. 2019 Dec;18(6):e13024. (PMID: 31389140)
      Stem Cell Res Ther. 2017 Oct 10;8(1):224. (PMID: 29017592)
      J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117346. (PMID: 37879506)
      Mol Hum Reprod. 2013 Aug;19(8):486-94. (PMID: 23612738)
      Mol Med Rep. 2024 Feb;29(2):. (PMID: 38131196)
      Clin Neurol Neurosurg. 2019 Jan;176:116-121. (PMID: 30554092)
      Redox Biol. 2021 Sep;45:102055. (PMID: 34214709)
      Sci Rep. 2017 Jan 24;7:41136. (PMID: 28117405)
      Methods Mol Biol. 2013;1036:47-61. (PMID: 23807785)
      Front Cell Dev Biol. 2021 Aug 05;9:658112. (PMID: 34422794)
      Reprod Sci. 2024 Mar 5;:. (PMID: 38441776)
      Methods Mol Biol. 2016;1416:123-46. (PMID: 27236669)
      Can J Physiol Pharmacol. 2019 Oct;97(10):963-970. (PMID: 31461309)
      Aging (Albany NY). 2017 Dec 27;9(12):2480-2488. (PMID: 29283885)
      Life Sci. 2019 Mar 1;220:44-49. (PMID: 30708097)
      Int J Cardiol. 2014 May 15;173(3):453-66. (PMID: 24679689)
      Essays Biochem. 2018 Jul 20;62(3):341-360. (PMID: 30030364)
      Curr Pharm Des. 2016;22(36):5526-5534. (PMID: 27510482)
      Daru. 2017 Oct 11;25(1):21. (PMID: 29020999)
      Stem Cells Int. 2016;2016:4062789. (PMID: 28053607)
      Sci Rep. 2015 Aug 07;5:12898. (PMID: 26250571)
      Reprod Sci. 2017 May;24(5):646-655. (PMID: 27613818)
      Reprod Biol Endocrinol. 2020 Jun 3;18(1):58. (PMID: 32493421)
      J Ethnopharmacol. 2020 Mar 25;250:111965. (PMID: 31185267)
      J Cell Physiol. 2020 Sep;235(9):6113-6126. (PMID: 32048305)
      Curr Pharm Des. 2016;22(18):2709-22. (PMID: 26881435)
      Electromagn Biol Med. 2017;36(1):45-54. (PMID: 27367918)
      Iran J Basic Med Sci. 2020 Feb;23(2):236-243. (PMID: 32405367)
      J Cell Biochem. 2018 Aug;119(8):6575-6583. (PMID: 29737539)
      Reprod Med Biol. 2020 Jul 20;20(1):13-19. (PMID: 33488279)
      Iran J Basic Med Sci. 2022 Jun;25(6):690-697. (PMID: 35949300)
      Exp Ther Med. 2019 May;17(5):4064-4072. (PMID: 31007743)
      Regul Toxicol Pharmacol. 2020 Feb;110:104544. (PMID: 31778716)
      J Zhejiang Univ Sci B. 2010 Aug;11(8):608-17. (PMID: 20669351)
      Behav Brain Res. 2022 Sep 5;433:114001. (PMID: 35809694)
      Microvasc Res. 2018 Jul;118:49-56. (PMID: 29476756)
      Int J Mol Sci. 2012 Dec 13;13(12):17104-20. (PMID: 23443132)
      Int J Mol Sci. 2023 Jul 06;24(13):. (PMID: 37446328)
      Biol Reprod. 2015 Sep;93(3):69. (PMID: 26203175)
      Hormones (Athens). 2023 Dec;22(4):715-724. (PMID: 37704921)
      DNA Cell Biol. 2020 Aug;39(8):1401-1409. (PMID: 32077751)
      J Obstet Gynaecol Res. 2021 May;47(5):1789-1803. (PMID: 33709493)
      J Orthop Surg Res. 2020 Jan 28;15(1):29. (PMID: 31992313)
      Stem Cells Int. 2021 Oct 15;2021:2229477. (PMID: 34691190)
      Mol Cell Endocrinol. 2012 Jun 5;356(1-2):24-30. (PMID: 21684319)
      Cell Stem Cell. 2018 Jun 01;22(6):824-833. (PMID: 29859173)
      Methods Enzymol. 1990;186:407-21. (PMID: 2233308)
      Stem Cells Int. 2019 Sep 12;2019:9782373. (PMID: 31611920)
      Front Endocrinol (Lausanne). 2022 Feb 18;13:787876. (PMID: 35250857)
      Phytomedicine. 2023 Aug;117:154908. (PMID: 37321077)
      Zhonghua Nei Ke Za Zhi. 1993 Oct;32(10):656-60. (PMID: 8156833)
      Sci Rep. 2020 Jan 23;10(1):1021. (PMID: 31974436)
      Int J Mol Med. 2018 Feb;41(2):739-748. (PMID: 29207024)
    • Contributed Indexing:
      Keywords: Inflammation; LY294002; Mesenchymal stem cells; Mitochondrial dynamic; Oxidative stress; PCOS; PI3K-AKT
    • الموضوع:
      Date Created: 20240427 Date Completed: 20240428 Latest Revision: 20240516
    • الموضوع:
      20240516
    • الرقم المعرف:
      PMC11056058
    • الرقم المعرف:
      10.1186/s13048-024-01422-3
    • الرقم المعرف:
      38678269